Eikon Therapeutics
Latest round
- Series D
Last raised
- Feb 2025
Total raised
- $1B
Investors
- 20
About Eikon Therapeutics
Founded in 2019 and based in Hayward, CA, Eikon Therapeutics, Inc. is a drug discovery and development business that analyzes single-molecule protein behaviour in living cells using superior engineering and high-performance computers. Co-founded by Robert Tjian, Luke Lavis, Xavier Darzacq and Eric Betzig, Eikon Therapeutics, Inc. In February 2025, Eikon Therapeutics, Inc.52 billion post-money. The company offers a drug discovery platform that assesses the impact of chemical compounds on the mobility of protein molecules in a cell using super-resolution fluorescence microscopy technology. The firm specializes in using single-molecule tracking (SMT) throughout the whole drug discovery paradigm, enabling the development of pharmaceuticals. Eikon's technology's capacity to collect photos and assess the dynamic mobility of proteins. The new technique can be used in secondary assays, compound optimization against targets, high-throughput screens, and other stages of the drug development process. Eikon's target is to develop new therapies for previously unsolvable targets by merging protein dynamics with a wide range of drug discovery assay platforms. Eikon's multidisciplinary team focuses on biochemistry, cell biology, medicinal chemistry, pharmacology, and single-molecule tracking.
Who invested in Eikon Therapeutics
20 investors across 4 rounds
See all investors in Eikon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eikon Therapeutics
Who invested in Eikon Therapeutics?
Eikon Therapeutics has 20 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eikon Therapeutics raised?
Eikon Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Eikon Therapeutics last raise money?
Eikon Therapeutics's most recent round on record is a Series D, in Feb 2025.
What does Eikon Therapeutics do?
Founded in 2019 and based in Hayward, CA, Eikon Therapeutics, Inc.
Where is Eikon Therapeutics headquartered?
Eikon Therapeutics is headquartered in Millbrae, US.
Which VCs invest in companies like Eikon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Eikon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Eikon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.